INS and diabetes mellitus: The protein-tyrosine phosphatase 1B (PTP1B), a reticular non-transmembrane enzyme, has been validated as therapeutic target for diabetes, obesity, and breast cancer, due to its role as negative regulator of insulin and leptin signaling [264].